Overview
* Edgewell Q4 net sales rose 3.8%, slightly beating analyst expectations
* Adjusted EPS for Q4 missed analyst expectations
* On Nov 13, company announced $100 mln share repurchase authorization
* Edgewell to sell Feminine Care business to Essity for $340 mln
Outlook
* Edgewell expects 2026 reported net sales to increase 0.5% to 3.5%
* Company projects 2026 GAAP EPS between $1.10 and $1.50
* Adjusted EPS for 2026 expected to be $2.15 to $2.55
Result Drivers
* INTERNATIONAL GROWTH - Co reports 6.9% organic sales growth in international markets, driven by volume and price gains
* PROMOTIONAL IMPACT - Increased promotional levels in North America offset volume gains, leading to a 0.6% organic sales decline
* DIVESTITURE STRATEGY - Sale of Feminine Care business to Essity for $340 mln marks strategic shift to focus on core personal care segments
Key Details
Metric Beat/Mis Actual Consensu
s s
Estimate
Q4 Sales Slight $537.20 $534.30
Beat* mln mln (6
Analysts
)
Q4 Miss $0.68 $0.80 (8
Adjusted Analysts
EPS )
Q4 Miss $40.30 $50.20
Adjusted mln mln (6
Operatin Analysts
g Income )
Q4 Gross $208.60
Profit mln
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
* The average consensus recommendation for the personal products peer group is "hold."
* Wall Street's median 12-month price target for Edgewell Personal Care Co ( EPC ) is $25.50, about 25.8% above its November 12 closing price of $18.91
* The stock recently traded at 7 times the next 12-month earnings vs. a P/E of 8 three months ago
Press Release:
For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)